Oxford BioTherapeutics
Employee Participants0
Total Rating0
Revenue$0
Operator of a biotechnology drug discovery firm intended to develop innovative antibody therapies to treat cancer. The company's focus lies in the creation and development of novel targeted oncology therapeutics with a focus on Antibody Drug Conjugates and Immune-Oncology treatments. Read More
Headquarters 94A Innovation Drive, Abingdon, OX14 4RZ, GBR
Website www.oxfordbiotherapeutics.com
70/100